About us

About Us

We take a different approach to business at Mundipharma. We don’t have the traditional pharmaceutical business model. Innovation and our entrepreneurial spirit guide everything we do and our success rate proves this approach works.

Our mission to substantially improve the quality of life of patients everywhere by alleviating the global burden of pain and needless suffering requires us to continually adapt to the changing business environment without losing sight of our values and principles.

Even with the rapid growth we are seeing across all of our markets, we have remained focused on being one of the leaders in the science of pain, as well as being independent and agile, nurturing our global community of experts, and being a diversified company with trusted products in the healthcare industry and at home.

Mundipharma is dedicated to bringing to patients with moderate to severe pain and debilitating diseases the benefit of innovative treatment options, continually expanding our fields of expertise across areas such as severe pain, oncology, respiratory disease, rheumatoid arthritis and antisepsis.

Mission

Mundipharma is dedicated to alleviating human suffering and improving quality of life for the human race.

Approach

As a network of independent associated companies, we are able to put patients at the heart of everything we do. This includes a commitment to providing affordable treatment, and focussing on specialist therapy areas in which we can make the most difference: Analgesia, Oncology, Ophthalmology, Respiratory, Specialty Care, and Consumer Health.

Principles

Our patient-centric approach is supported by innovation to enable scientific breakthroughs that result in better medicines as well as entrepreneurship to create growth, which increases the number of patients we can reach.

Building a strong product pipeline and a varied portfolio of products through strategic partnerships and in-licensing.

Forging a strong sales and marketing organisation focused on the correct product(s) for each patient.

Providing effective medical education to assist in the growing acceptance of pain management medications.

Company History

Mundipharma is continuing to grow and is now working on the commercialisation of innovative products to manage pain and treat asthma, rheumatoid arthritis and non-Hodgkin’s lymphoma, just to name a few

1957

First Mundipharma entity founded in Switzerland

1973

Mundipharma developed prolonged release technology for treating chronic pain

1991

Opening of Mundipharma’s operations in Japan.

1993

Opening of Mundipharma’s operations in China.

1998

Opening of Mundipharma’s operations in South Korea.

2004